G
Gillian Divard
Researcher at University of Paris
Publications - 31
Citations - 404
Gillian Divard is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 12 publications receiving 119 citations. Previous affiliations of Gillian Divard include French Institute of Health and Medical Research & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study
Alexandre Loupy,Olivier Aubert,Babak J. Orandi,Maarten Naesens,Yassine Bouatou,Marc Raynaud,Gillian Divard,Annette M. Jackson,Denis Viglietti,Magali Giral,Nassim Kamar,Olivier Thaunat,Emmanuel Morelon,Michel Delahousse,Dirk Kuypers,Alexandre Hertig,Eric Rondeau,Elodie Bailly,Farsad Eskandary,Georg A. Böhmig,Gaurav Gupta,Denis Glotz,Christophe Legendre,Robert A. Montgomery,Mark D. Stegall,Jean Philippe Empana,Xavier Jouven,Dorry L. Segev,Carmen Lefaucheur +28 more
TL;DR: The iBox system showed accuracy when assessed at different times of evaluation post-transplant, was validated in different clinical scenarios, and outperformed previous risk prediction scores as well as a risk score based solely on functional parameters including estimated glomerular filtration rate and proteinuria.
Journal ArticleDOI
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.
Nathalie Chavarot,Antoine Morel,Marianne Leruez-Ville,Estelle Vilain,Gillian Divard,Carole Burger,Alexandra Serris,Alexandra Serris,Rebecca Sberro-Soussan,Frank Martinez,Lucile Amrouche,L Bererhi,Fanny Lanternier,Fanny Lanternier,Christophe Legendre,Julien Zuber,Dany Anglicheau,Anne Scemla +17 more
TL;DR: In this article, the authors analyzed the humoral response in kidney transplant recipients (KTRs) without a history of SARS-CoV-2 infection who received three injections of BNT162b2-mRNA COVID-19 vaccine.
Journal ArticleDOI
Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes
Peter P. Reese,Peter P. Reese,Olivier Aubert,Maarten Naesens,Edmund Huang,Vishnu S. Potluri,Dirk Kuypers,Antoine Bouquegneau,Gillian Divard,Marc Raynaud,Yassine Bouatou,Ashley Vo,Denis Glotz,Christophe Legendre,Carmen Lefaucheur,Stanley C. Jordan,Jean-Philippe Empana,Xavier Jouven,Alexandre Loupy +18 more
TL;DR: Donor kidney histology assessment during allocation did not provide substantial incremental value in ascertaining organ quality and many kidneys discarded on the basis of biopsy findings would likely benefit United States patients who are wait listed.
Journal ArticleDOI
Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering
T. Vaulet,Gillian Divard,Olivier Thaunat,Evelyne Lerut,Aleksandar Senev,Olivier Aubert,Elisabet Van Loon,Jasper Callemeyn,Marie-Paule Emonds,Amaryllis H. Van Craenenbroeck,Katrien De Vusser,Ben Sprangers,Maud Rabeyrin,Valérie Dubois,Dirk Kuypers,Maarten De Vos,Alexandre Loupy,Bart De Moor,Maarten Naesens +18 more
TL;DR: In this paper, a semisupervised clustering approach for the identification of clinically meaningful novel phenotypes of kidney transplant rejection has been developed and validated, and a novel visualization tool presents disease phenotypes and severity in a continuous manner, as a complement to the discrete clusters.
Journal ArticleDOI
Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept.
Nathalie Chavarot,Gillian Divard,Anne Scemla,Lucile Amrouche,Olivier Aubert,Marianne Leruez-Ville,Marc Olivier Timsit,Claire Tinel,Julien Zuber,Christophe Legendre,Dany Anglicheau,Rebecca Sberro-Soussan +11 more
TL;DR: CMV diseases under belatacept were atypical, with late‐onset disease, high CMV seropositivity, increased severe and tissue‐invasive disease rates, and life‐threatening diseases in KTRs.